Yipinhong Pharmaceutical Co Ltd Class A Total Assets
Yipinhong Pharmaceutical Co Ltd Class A total assets. Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) holds total assets worth CN¥4.49 Billion CNY (≈ $656.73 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Yipinhong Pharmaceutical Co Ltd Class A (300723) total market value for the company's overall valuation and market capitalisation.
Total Assets of Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
Total assets of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's total assets have evolved over time, based on quarterly financial data. See latest Yipinhong Pharmaceutical Co Ltd Class A stock price today for real-time trading data and today's change.
Yipinhong Pharmaceutical Co Ltd Class A - Asset Composition Analysis
Yipinhong Pharmaceutical Co Ltd Class A Total Assets Breakdown (December 2025)
Yipinhong Pharmaceutical Co Ltd Class A total assets breakdown as of December 2025. Yipinhong Pharmaceutical Co Ltd Class A's total assets of CN¥4.49 Billion consist of 27.2% current assets and 72.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 12.8% |
| Accounts Receivable | CN¥205.33 Million | 5.1% |
| Inventory | CN¥215.91 Million | 5.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥447.63 Million | 11.1% |
| Goodwill | CN¥255.94K | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Yipinhong Pharmaceutical Co Ltd Class A (300723) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yipinhong Pharmaceutical Co Ltd Class A's current assets represent 27.2% of total assets in 2025, a decrease from 37.4% in 2013.
- Cash Position: Cash and equivalents constituted 12.8% of total assets in 2025, up from 7.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 22.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 11.1% of total assets.
Yipinhong Pharmaceutical Co Ltd Class A Competitors by Total Assets
Key competitors of Yipinhong Pharmaceutical Co Ltd Class A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.44 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥25.73 Billion |
Yipinhong Pharmaceutical Co Ltd Class A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.49 | 1.33 | 1.73 |
| Quick Ratio | 1.32 | 1.13 | 1.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥607.31 Million | CN¥481.98 Million | CN¥547.70 Million |
Yipinhong Pharmaceutical Co Ltd Class A - Advanced Valuation Insights
This section examines the relationship between Yipinhong Pharmaceutical Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.41 |
| Latest Market Cap to Assets Ratio | 0.46 |
| Asset Growth Rate (YoY) | -8.2% |
| Total Assets | CN¥4.04 Billion |
| Market Capitalization | $1.87 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Yipinhong Pharmaceutical Co Ltd Class A's assets below their book value (0.46x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Yipinhong Pharmaceutical Co Ltd Class A's assets decreased by 8.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
The table below shows the annual total assets of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.04 Billion ≈ $591.51 Million |
-8.22% |
| 2024-12-31 | CN¥4.40 Billion ≈ $644.46 Million |
-0.03% |
| 2023-12-31 | CN¥4.41 Billion ≈ $644.63 Million |
+7.49% |
| 2022-12-31 | CN¥4.10 Billion ≈ $599.73 Million |
+10.64% |
| 2021-12-31 | CN¥3.70 Billion ≈ $542.07 Million |
+72.69% |
| 2020-12-31 | CN¥2.15 Billion ≈ $313.90 Million |
+19.52% |
| 2019-12-31 | CN¥1.79 Billion ≈ $262.64 Million |
+0.78% |
| 2018-12-31 | CN¥1.78 Billion ≈ $260.61 Million |
+20.18% |
| 2017-12-31 | CN¥1.48 Billion ≈ $216.85 Million |
+96.98% |
| 2016-12-31 | CN¥752.32 Million ≈ $110.09 Million |
+19.31% |
| 2015-12-31 | CN¥630.56 Million ≈ $92.27 Million |
-14.07% |
| 2014-12-31 | CN¥733.80 Million ≈ $107.38 Million |
+78.42% |
| 2013-12-31 | CN¥411.27 Million ≈ $60.18 Million |
-- |
About Yipinhong Pharmaceutical Co Ltd Class A
ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale a… Read more